A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants

NCT07341152 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain Management

Interventions

DRUG: LTG-001 SDD
DRUG: LTG-001 Formulation A Prototype 1
DRUG: LTG-001 Formulation B Prototype 2
DRUG: LTG-001 Formulation B prototype 2

Sponsor

Latigo Biotherapeutics